CRISPR/Cas9 genome editing to treat sickle cell disease
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Huvudupphovsman: | Ullah, Mohammad |
---|---|
Övriga upphovsmän: | Islam, Farzana |
Materialtyp: | Lärdomsprov |
Språk: | English |
Publicerad: |
Brac University
2023
|
Ämnen: | |
Länkar: | http://hdl.handle.net/10361/19355 |
Liknande verk
-
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
av: Maria, Amatul
Publicerad: (2020) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
av: Shaikat, Mahdi Mubin
Publicerad: (2023) -
A review on CRISPR-Cas system based applications in Oncology
av: Sadia, Mir
Publicerad: (2022) -
A review on CRISPR Technology as an Antiviral Tool
av: Srishti, Sanjida Ahmed
Publicerad: (2023) -
CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
av: Eva, Israt Ara Jannat
Publicerad: (2023)